Publication:
Transarterial Embolization of Acute Gastrointestinal Bleeding

dc.authorscopusid55898513200
dc.authorscopusid57193457782
dc.authorscopusid6603778576
dc.authorscopusid7007082917
dc.contributor.authorIdil Soylu, A.
dc.contributor.authorUzunkaya, F.
dc.contributor.authorBelet, Ü.
dc.contributor.authorAkan, H.
dc.date.accessioned2025-12-11T00:28:44Z
dc.date.issued2021
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Idil Soylu] Ayşegül, Department of Radiology, Ondokuz Mayis University, Medical School, Samsun, Turkey; [Uzunkaya] Fatih, Department of Radiology, Ondokuz Mayis University, Medical School, Samsun, Turkey; [Belet] Ümit, Department of Radiology, Tepecik Training and Research Hospital, Izmir, Izmir, Turkey; [Akan] Hüseyin, Department of Radiology, Ondokuz Mayis University, Medical School, Samsun, Turkeyen_US
dc.description.abstractTransarterial embolization (TAE) is a minimally invasive treatment method developed alternative to surgery for acute gastrointestinal bleeding (AGIB). The aim of this study was to evaluate the efficacy and outcome of TAE in AGIB patients. The data of 30 patients who underwent TAE with complaint of AGIB between January 2007- May 2020 was collected retrospectively. The etiology of hemorrhage, localization and type of lesion, embolizing agent used, and postprocedural complications were recorded. Lesions were classified as pseudoaneurysm (PA), extravasation, pathological tumor vascularity and vasospasm. A total of 22 patients, 5 females, were included in the study. The most common underlying cause was tumors (n=15, 50%). The most common lesion detected on angiograms was pathological tumor vascularity. Embolizing agents used were N-butyl-2-cyanoacrylate in five patients, coils in three patients, polyvinyl alcohol particles in six patients and microsphere in seven patients. The technical success rate was 90.9%, and two patients developed rebleeding in the early postprocedural period. TAE is a safe, effective and minimally invasive method in emergency treatment of patients with AGIB. © 2021 Ondokuz Mayis Universitesi. All rights reserved.en_US
dc.identifier.doi10.52142/omujecm.38.si.gastro.8
dc.identifier.endpage60en_US
dc.identifier.issn1309-4483
dc.identifier.issn1309-5129
dc.identifier.scopus2-s2.0-85105522156
dc.identifier.scopusqualityQ4
dc.identifier.startpage56en_US
dc.identifier.urihttps://doi.org/10.52142/omujecm.38.si.gastro.8
dc.identifier.urihttps://hdl.handle.net/20.500.12712/36588
dc.identifier.volume38en_US
dc.language.isoenen_US
dc.publisherOndokuz Mayis Universityen_US
dc.relation.ispartofJournal of Experimental and Clinical Medicine (Turkey)en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAcute Gastrointestinal Bleedingen_US
dc.subjectEmbolic Agentsen_US
dc.subjectTransarterial Embolizationen_US
dc.titleTransarterial Embolization of Acute Gastrointestinal Bleedingen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files